NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
This funding opportunity supports early-stage postdoctoral researchers in transitioning to independent faculty positions by providing financial resources for conducting basic experimental studies involving human participants in cancer research.
The National Institutes of Health, within the U.S. Department of Health and Human Services and specifically administered by the National Cancer Institute, offers the Pathway to Independence Award for Early-Stage Postdoctoral Researchers under the K99/R00 mechanism. This program is part of NIH’s broader mission to cultivate a strong pipeline of independent biomedical researchers capable of addressing national health challenges. The initiative is designed to support postdoctoral researchers who are nearing readiness for independence and who require only a limited additional mentored period before transitioning into faculty roles. The program emphasizes strengthening the cancer research workforce, particularly in areas such as cancer control, cancer prevention, and cancer data science. The primary purpose of this funding opportunity is to facilitate a structured transition from mentored postdoctoral training to independent research careers. The award is divided into two sequential phases: the K99 mentored phase, which can last up to two years, and the R00 independent phase, which can extend for up to three years. The K99 phase provides salary support and research development funding to enhance the candidate’s training and career readiness, while the R00 phase provides independent research funding contingent upon securing a tenure-track or equivalent faculty position. The program requires applicants to propose basic experimental studies involving human participants that align with NIH definitions of both clinical trials and basic research. Funding supports a range of allowable costs, including salary, research expenses, training-related costs, and travel. During the K99 phase, salary support is capped at $100,000 annually, with up to $30,000 per year available for research development expenses. In the R00 phase, total costs may not exceed $249,000 per year, inclusive of all direct and indirect costs. The program does not require cost sharing or matching funds. However, strict adherence to NIH budgeting guidelines and institutional salary structures is required. Certain costs, such as administrative salaries, are not allowable under the award. Eligibility for the program is broad in terms of institutional participation but narrowly defined for individual applicants. Eligible organizations include higher education institutions, nonprofits, for-profit entities, and government agencies within the United States. However, foreign institutions are not eligible to apply. Individual applicants must be in mentored postdoctoral positions with no more than two years of postdoctoral research experience at the time of application and must not have previously held independent research positions or major NIH funding. Applicants must hold a doctoral degree and demonstrate readiness to transition to independence within the award timeline. The application process requires submission through NIH-approved systems such as ASSIST, Grants.gov, or institutional system-to-system solutions. Applicants must comply with the SF424 Application Guide and include required components such as an institutional nomination letter, research plan, career development plan, and supporting documentation. Applications are reviewed through NIH’s peer review system based on criteria including candidate potential, research plan quality, mentorship, and institutional environment. A pre-application webinar may be offered to provide guidance to applicants. The funding opportunity operates on a recurring schedule with multiple submission deadlines each year, typically in February, June, and October. Applications are due by 5:00 PM local time of the applicant organization. Review cycles follow a structured timeline, with scientific review, advisory council review, and earliest start dates occurring several months after submission. The program has an expiration date of May 25, 2026, after which a new funding announcement may be issued. Applicants are encouraged to apply early and ensure compliance with all submission requirements to avoid delays or rejection.
Award Range
$100,000 - $747,000
Total Program Funding
Not specified
Number of Awards
Not specified
Matching Requirement
No
Additional Details
K99 phase provides up to 100000 per year salary plus 30000 research costs; R00 phase provides up to 249000 per year for up to 3 years total support up to 5 years
Eligible Applicants
Additional Requirements
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Required Registrations
Geographic Eligibility
All
Strong applications clearly demonstrate readiness for independence include a well-structured transition plan and align closely with NCI priorities while presenting a feasible and impactful research proposal
Application Opens
November 8, 2023
Application Closes
May 24, 2026
Subscribe to view contact details

